This article, published in Pharmafocus' April 2019 issue, features expert insights on the 21st Century Cures Act's relation to the expanding use of real-world evidence (RWE), as shared by ICON's Jim Carroll (VP, RWE) and Vicki Anastasi (VP & Global Head, RWE, Late Phase Research).Download Article
Optimise Your RWE Investments
What is the Value of Real World Evidence in Oncology in HTA Appraisals?
Real World Evidence Across the Product Lifecycle
Harnessing Technology to Maximise Real World Evidence Value
RWE Generation Cross Sectional Studies and Medical Chart Review